Cartagenia is a Belgian startup founded in 2008, specializing in delivering diagnostic knowledge, software, and database systems focused on enabling genetic labs and clinicians to conduct clinically relevant genetic analyses efficiently. The company aims to facilitate high-quality genetic interpretation and counseling for patients and caregivers. Cartagenia secured a noteworthy €4.25M in its last venture round investment on 30 May 2014, with investors including KU Leuven Research & Development and Digital-Healthcare.
Cartagenia
Founded 2008
Belgium
1 employees
Series Unknown
Total: $6.45M
Belgium
1 employees
Series Unknown
Total: $6.45M
General Information
Get notified when Cartagenia moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Cartagenia
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
Belgium Market
About Cartagenia
Taxonomy: Genetic Analysis, Diagnostic Knowledge, Software Systems, Database Systems, Clinical Genetics, Genetic Interpretation, Counseling Services
Funding Rounds & Investors (2)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | •••••• | 2 | •••• •••• | 30 May 2014 |
| Venture Round | •••••• | 2 |
|
06 Oct 2011 |
Cartagenia Alternatives & Competitors
Cartagenia vs
-logo.jpg "Clear Genetics (YC W17, acquired by Invitae)"){kind=logo}
Clear Genetics (YC W17, acquired by Invitae)
United States
We are reinventing the way people around the world access genetic expertise. Clear Genetic is deve...
Series Unknown
1 employees
Biotechnology, Health Care
Cartagenia vs
ReCode Therapeutics
United States
Powering the next wave of genetic medicines through superior delivery
Series B
58 employees
Biopharma, Biotechnology
Cartagenia vs
FAQ About Cartagenia
Cartagenia delivers diagnostic knowledge, software and database systems, and related services to enable genetic labs and clinicians to perform clinically relevant genetic analyses quickly and efficiently, and allow them to offer patients and carers high quality genetic interpretation and counseling.
Cartagenia was founded in 2008.
Cartagenia is headquartered in Belgium.
Cartagenia has approximately 1 employees.
Cartagenia has completed 2 funding rounds, raising a total of $6.45M. The latest funding stage is Series Unknown.
Top alternatives and competitors to Cartagenia include Clear Genetics (YC W17, acquired by Invitae), ReCode Therapeutics, VIAGEN Genetic Diseases Assesment Center, ADNTRO GENETICS, Gene Health. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cartagenia and Clear Genetics (YC W17, acquired by Invitae) are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Don't just browse. Track.
Signal Tracker monitors Cartagenia and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.
